Psychiatry 36 Halgravez PereaL.Salinas TllezJ.Martnez GonzlezG.Rodrguez LuisO
Data sources and searches Articles were searched regardless of region, publication type, language, or sample size
Who these treatments are for GLP-1 medications are approved for adults with:Type 2 diabetesObesity (BMI of 30 kg/m or higher) A BMI of 27 kg/m or higher with at least one weight-related condition such as high blood pressure Among individuals with a BMI of 27 kg/m or more, additional benefits have been found
While more research is needed, these studies show support for GLP-1s in preventing the weight gain associated with quitting smoking
Identify revenue streams: Establish monetization models across subscription fees, medication markups, lab coordination margins, and ancillary clinical coaching
It is retained for a certain period in accordance with internal policies and relevant laws (refer to retention and use period), and then destroyed